胰岛素强化治疗重症肺炎45例临床分析

目的:探讨胰岛素强化治疗在重症肺炎中的临床疗效.方法:将我院2008年1月至2011年12月收治的87例重症肺炎患者随机分为对照组(n=42)和治疗组(n=45),对照组予以常规治疗,治疗组予以胰岛素强化治疗,比较两组临床效果.结果:治疗组治疗7 d后APACHEⅡ评分、C反应蛋白均明显低于对照组,P<0.05;治疗组住院时间和病死率均明显少于对照组,P<0.05.结论:胰岛素强化治疗可以降低重症肺炎患者的住院时间和死亡率.

Clinical Analysis of Insulin Intensification Therapy for 45 Patients with Severe Pneumonia

Objective： To explore the clinical effect of insulin intensification therapy for patients with severe pneumonia. Methods： 87 patients with severe pneumonia were randomly divided into control group （n--42） and treatment group from Jan 2008 to Dec 2011. The control group and the treatment group were treated by routine measures and insulin intensification. The therapeutic effect was compared between the two groups. Results： The APACHE II assessment and C reactive protein in the treatment group were significantly lower than those in the control group after treatment 7 days, as well as the duration stay in hospital and mortality, all P〈0.05. Conclusion： Insulin intensification therapy can short hospital stay and reduce the mortality of patient with severe pneumonia.